CURE
Genomics ETF
VanEck Genomics and Healthcare Innovators UCITS ETF
CURE
Genomics ETF
VanEck Genomics and Healthcare Innovators UCITS ETF
_FundBlocks.Text.ISIN:
IE000B9PQW54
Fund Description
Technology is transforming healthcare. Not only are genomic treatments for several diseases becoming more affordable, but also digitalized healthcare is growing fast. VanEck’s Genomics and Healthcare Innovators UCITS ETF invests in the businesses pioneering ways to treat disease and connect with patients.
-
_FundBlocks.Text.NAV$22.34
as of 03 Feb 2026 -
_FundBlocks.FundDetails.YtdReturns0.21_FundBlocks.Postfix.PercentSign
as of 03 Feb 2026 -
_FundlistingEU.Headers.TotalNetAssets$16.5_FundBlocks.Postfix.Million
as of 03 Feb 2026 -
_FundBlocks.Text.Total_Expense_Ratio0.35_FundBlocks.Postfix.PercentSign
-
_FundBlocks.Text.Inception_Date02 Sep 2022
-
SFDR ClassificationArticle 9